D-0556-2025 Class II Ongoing
FDA drug recall D-0556-2025 was initiated by AEQUITA PHARMACY on Jul 18, 2025 and is designated Class II. Reason for recall: Lack of Processing Controls. The recall status is ongoing. Affected quantity: 160 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 13, 2025
- Initiation Date
- Jul 18, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 160 vials
Product description
Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Reason for recall
Lack of Processing Controls.
Distribution pattern
MA
Code information
All Lots within expiry.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0556-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026